{"id":39050,"date":"2020-10-15T07:45:22","date_gmt":"2020-10-15T07:45:22","guid":{"rendered":"https:\/\/i-base.info\/htb\/?p=39050"},"modified":"2020-10-16T08:13:33","modified_gmt":"2020-10-16T08:13:33","slug":"hiv-therapy-glasgow-2020","status":"publish","type":"post","link":"https:\/\/i-base.info\/htb\/39050","title":{"rendered":"HIV Therapy Glasgow 2020"},"content":{"rendered":"
\"\"5-8 October 2020, virtual conference<\/span><\/strong><\/div>\n
\n

Introduction<\/h2>\n<\/div>\n
\n

Simon Collins, HIV i-Base<\/span><\/strong><\/p>\n<\/div>\n

\n

This year, the biennial Glasgow HIV Congress was held from 5-8 October as a virtual meeting.<\/span><\/strong><\/p>\n<\/div>\n

\n

The conference website is easy to navigate, with most oral presentations already prerecorded but with presenters also being online for Q&A discussions afterwards.<\/span><\/p>\n<\/div>\n

\n

The programme this year is particularly strong, with a focus on COVID-19 and how it affects people living with HIV and our care, and on important concerns about women’s health and weight gain experienced by some people as a side effect of ART. As always, there are also exciting studies on next generation treatment.<\/span><\/p>\n<\/div>\n

\n

For registered delegates, webcasts are being posted on the same day of the oral presentation and the meeting will be open access to everyone when the meeting closes.<\/span><\/p>\n<\/div>\n

\n

https:\/\/virtual.hivglasgow.org<\/span><\/a><\/p>\n<\/div>\n

\n

Reports from the meeting in this issue of HTB with be linked below as they become available.<\/span><\/p>\n<\/div>\n

\n